Literature DB >> 25688924

'We had to change to single beds because I itch in the night': a qualitative study of the experiences, attitudes and approaches to coping of patients with cutaneous T-cell lymphoma.

T Beynon1,2, L Selman2, E Radcliffe2, S Whittaker3, F Child3, D Orlowska3, C Morgans3, S Morris4, R Harding2.   

Abstract

BACKGROUND: Primary cutaneous T-cell lymphoma (CTCL) is a rare but prevalent condition which can have a significant impact on many aspects of quality of life. However, there is little evidence of patients' lived experience of CTCL.
OBJECTIVES: To understand in greater depth patients' experiences of living and coping with CTCL, and to inform the development of models of care for this population in line with U.K.
METHODS: Semi-structured interviews were conducted with a purposive sample of patients with CTCL who attended an inner-city teaching hospital. Participants were purposively selected according to their disease stage, age, sex and ethnicity.
RESULTS: Nineteen patients with CTCL (stages IB-IVB), aged between 41 and 83 years, participated in a single interview. This included 10 men; 15 people identified themselves as white British. Interviews lasted a median of 55 (range 28-170) min. Two main themes emerged: issues regarding diagnosis, particularly a perceived delay in diagnosis, and the impact of CTCL (subthemes related to physical well-being, practical concerns and psychological and social well-being and coping).
CONCLUSIONS: Findings from this study illuminate the diverse effects of CTCL on patients' lives. The universal experience of delays in diagnosis was striking and a concern to patients. The disease, particularly its physical symptoms, had a significant impact on patients' lives, including employment, leisure and relationships. Despite the symptom burden and its impact, participants described effective coping strategies such as drawing on social support, maintaining normal lives and becoming well informed about CTCL. Proactive holistic assessment and management of the range of patient concerns is needed in providing care for patients with CTCL and their family and friends.
© 2015 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2015        PMID: 25688924     DOI: 10.1111/bjd.13732

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

1.  Priorities for Rural Lymphoma Survivors: A Qualitative Study.

Authors:  Lillian Chen; Jackelyn B Payne; Kaylin V Dance; Conner B Imbody; Cathy D Ho; Amy A Ayers; Christopher R Flowers
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-10-19

2.  Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Cutaneous T Cell Lymphoma.

Authors:  Jennifer A Salant; Niloufer Khan; Judith E Nelson; Moe Norton-Westbrook; Anjali V Desai
Journal:  J Palliat Med       Date:  2021-12-31       Impact factor: 2.947

3.  Extensive Cutaneous T-Cell Lymphoma of the Feet Treated with High-Dose-Rate Brachytherapy and External Beam Radiation.

Authors:  Joy Tao; Courtney Hentz; Michael L Mysz; Issra Rashed; David Eilers; James Swan; Rebecca Tung; Bahman Emami
Journal:  Case Rep Dermatol Med       Date:  2018-08-07

4.  Conceptual framework for living with and beyond cancer: A systematic review and narrative synthesis.

Authors:  Clair Le Boutillier; Stephanie Archer; Claire Barry; Alex King; Louise Mansfield; Catherine Urch
Journal:  Psychooncology       Date:  2019-03-25       Impact factor: 3.894

5.  Determination of Alteration in Micromeritic Properties of a Solid Dispersion: Brunauer-Emmett-Teller Based Adsorption and Other Structured Approaches.

Authors:  Lovepreet Singh; Lakhvir Kaur; Gurjeet Singh; R K Dhawan; Manjeet Kaur; Navdeep Kaur; Prabhpreet Singh
Journal:  AAPS PharmSciTech       Date:  2022-07-28       Impact factor: 4.026

6.  S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021.

Authors:  Edgar Dippel; Chalid Assaf; Jürgen C Becker; Michael von Bergwelt-Baildon; Sophie Bernreiter; Antonio Cozzio; Hans T Eich; Khaled Elsayad; Markus Follmann; Stephan Grabbe; Uwe Hillen; Wolfram Klapper; Claus-Detlev Klemke; Carmen Loquai; Frank Meiss; Christina Mitteldorf; Ulrike Wehkamp; Dorothee Nashan; Jan P Nicolay; Ilske Oschlies; Max Schlaak; René Stranzenbach; Rose Moritz; Christoph Stoll; Tibor Vag; Michael Weichenthal; Marion Wobser; Rudolf Stadler
Journal:  J Dtsch Dermatol Ges       Date:  2022-04       Impact factor: 5.231

7.  Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma.

Authors:  Pierluigi Porcu; Stacie Hudgens; Steven Horwitz; Pietro Quaglino; Richard Cowan; Larisa Geskin; Marie Beylot-Barry; Lysbeth Floden; Martine Bagot; Athanasios Tsianakas; Alison Moskowitz; Auris Huen; Brigitte Dreno; Stéphane Dalle; Dolores Caballero; Mollie Leoni; Stephen Dale; Fiona Herr; Madeleine Duvic
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2020-09-18

Review 8.  Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a systematic review of the literature.

Authors:  R Ottevanger; S van Beugen; A W M Evers; R Willemze; M H Vermeer; K D Quint
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-08-14       Impact factor: 9.228

9.  Current measures are not sufficient: an interview-based qualitative assessment of quality of life in cutaneous T-cell lymphoma.

Authors:  T S Bhat; C M Herbosa; A R Rosenberg; O Sogade; D B Jeffe; N Mehta-Shah; Y R Semenov; A C Musiek
Journal:  Br J Dermatol       Date:  2020-08-02       Impact factor: 9.302

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.